Vanguard Group Inc. Buys 1,101,154 Shares of Perrigo Company plc $PRGO

Vanguard Group Inc. lifted its stake in Perrigo Company plc (NYSE:PRGO) by 7.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,983,369 shares of the company’s stock after buying an additional 1,101,154 shares during the quarter. Vanguard Group Inc. owned about 0.11% of Perrigo worth $208,568,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Amundi raised its position in shares of Perrigo by 11.7% during the 1st quarter. Amundi now owns 5,292 shares of the company’s stock valued at $148,000 after purchasing an additional 556 shares during the period. Goldman Sachs Group Inc. raised its position in shares of Perrigo by 126.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,159,768 shares of the company’s stock valued at $32,520,000 after purchasing an additional 647,982 shares during the period. United Services Automobile Association bought a new stake in shares of Perrigo during the 1st quarter valued at $250,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Perrigo by 6.7% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 513,112 shares of the company’s stock valued at $14,388,000 after purchasing an additional 32,151 shares during the period. Finally, Geneos Wealth Management Inc. raised its position in shares of Perrigo by 439.1% during the 1st quarter. Geneos Wealth Management Inc. now owns 965 shares of the company’s stock valued at $27,000 after purchasing an additional 786 shares during the period. Institutional investors own 95.91% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently commented on PRGO. Jefferies Financial Group restated a “hold” rating on shares of Perrigo in a research report on Thursday, February 26th. Argus raised Perrigo to a “hold” rating in a research note on Wednesday, January 14th. Weiss Ratings downgraded Perrigo from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, April 29th. Canaccord Genuity Group decreased their target price on Perrigo from $20.00 to $17.00 and set a “buy” rating on the stock in a research note on Friday, February 27th. Finally, Zacks Research raised Perrigo from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Perrigo presently has a consensus rating of “Hold” and a consensus price target of $19.33.

Perrigo Stock Performance

Perrigo stock opened at $11.71 on Friday. The company has a market cap of $1.62 billion, a PE ratio of -0.89, a price-to-earnings-growth ratio of 1.38 and a beta of 0.52. The company has a quick ratio of 1.63, a current ratio of 2.72 and a debt-to-equity ratio of 1.45. The company’s 50-day moving average price is $10.99 and its 200-day moving average price is $13.59. Perrigo Company plc has a twelve month low of $9.23 and a twelve month high of $28.43.

Perrigo (NYSE:PRGO) last released its earnings results on Wednesday, May 6th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.04. The firm had revenue of $841.80 million for the quarter, compared to the consensus estimate of $1.04 billion. Perrigo had a positive return on equity of 9.96% and a negative net margin of 43.50%.The company’s revenue for the quarter was down 7.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.60 EPS. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, equities research analysts forecast that Perrigo Company plc will post 2.12 EPS for the current fiscal year.

Perrigo Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Stockholders of record on Friday, May 29th will be given a dividend of $0.29 per share. The ex-dividend date of this dividend is Friday, May 29th. This represents a $1.16 annualized dividend and a dividend yield of 9.9%. Perrigo’s payout ratio is currently -8.85%.

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.